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Abstract

SINGLE-PARTICLE CRYO-EM OF THE RYANODINE RECEPTOR FROM SKELETAL
MUSCLE: RECONSTITUTION INTO NANODISCS AND THE CONFORMATIONAL
EFFECTS OF MAGNESIUM
Alex H. Will,
Bachelor of Science, University of Virginia 2014
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science in
Physiology and Biophysics at Virginia Commonwealth University.
Virginia Commonwealth University
Richmond, Virginia
August, 2017
Director: Montserrat Samsó, Ph. D.
Department of Physiology and Biophysics

The RyR1 acts as an intracellular calcium channel that allows passage of Ca2+ from the
sarcoplasmic reticulum to the cytoplasm; this increase in cytosolic Ca2+ is required for
excitation-contraction coupling. Certain mutations in RyR1 have been directly linked to
malignant hyperthermia (MH) and central core disease. In a series of studies, the role of Mg2+
has been explored as it pertains to MH, and it has been determined that dysregulation of Mg2+
can even lead to MH in patients without mutations. Consequently, the aim of the study was to
insert the RyR1 into nanodiscs, small, circular lipid bilayers used to solubilize membrane
proteins, and to use cryo-electron microscopy to assess the conformation of the RyR1 in the
presence of Mg2+ and AMP-PCP. Particle reconstruction generated a 9.0 Å resolution map that

confirmed successful incorporation of the RyR1 into nanodiscs and allowed visualization of the
RyR1 in a physiological closed state.
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1. Introduction

1.1. Ryanodine Receptor
1.1.1. Role in Excitation-Contraction Coupling
Throughout muscle types and even in brain tissue, there exist three major forms of the ryanodine
receptor; each are given the abbreviation RyR followed by numbers one through three.
Ryanodine receptor 1 (RyR1) is expressed predominately in skeletal muscle, ryanodine receptor
2 (RyR2) in cardiomyocytes, and ryanodine receptor 3 (RyR3) in brain cells.1,2 Of note, all three
isoforms are expressed in the brain to some extent. Each of the ryanodine receptors assemble as
tetramers and act as intracellular calcium channels that release Ca2+ ions from the sarcoplasmic
or endoplasmic reticulum into the cytoplasmic space. Regarding the case of RyR1, the calcium
release is modulated through direct physical connection to the CaV1.1, or the dihydropyridine
receptor (DHPR); the DHPR responds to nervous stimulation and activates (opens) the RyR1 to
allow Ca2+ to flow from the SR to the cytoplasm. This direct contact is at the triad junction,
where the transverse (T) tubule meets the endoplasmic or sarcoplasmic reticulum (ER or SR,
respectively) on both sides of the tubule.3
In the case of the RyR2, calcium-induced calcium release is the means of Ca2+ efflux from the
SR since the RyR2 is not directly opposing the CaV1.2. The T tubule meets the sarcoplasmic
reticulum at a dyad. There, a neuronal impulse allows Ca2+ into the cell, activating the RyR2. Of
note, it is referred to as a dyad because the opposition to the T tubule is only on one side.4

3

The cytosolic Ca2+ is required for excitation-contraction coupling leading to muscle contraction.
The increased level of cytosolic Ca2+ allows for binding to troponin C of the troponin complex.
This results in a conformational change of troponin I and tropomyosin so that the myosin binding
site of an actin filament is exposed. Myosin may then bind to its respective site on the actin
filament, and contraction can proceed through cross-bridge cycling. The figure below
summarizes the DHPR (L-type Ca2+ channel) interaction with the ryanodine receptor, the role of
the ryanodine receptor in Ca2+ release, the role of Ca2+ in troponin binding, and the opposition of
the T-tubule to the SR (Figure 1).5

Figure 1. Diagram of RyR1 role in Ca2+ release and muscle contraction adapted from Bernstein
et al. (2013)5
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1.1.2. Mutations in the Ryanodine Receptor
Mutations in the type of isoform of the ryanodine receptor result in different pathologies due to
their respective locations in different organs. A 2015 paper cites that over 500 mutations in the
primary sequence of RyR1 and RyR2 have been shown to result in disease.6 Of these, select
mutations in the primary sequence of RyR1 can lead to central core disease (CCD) and also
malignant hyperthermia (MH). A 2014 paper discusses 13 mutations that have been studied for
their causal role in MH; these mutations typically cluster in the N-terminal and central domains,
but there are instances of C-terminal domain mutations leading to MH.7,8 There is no routine
testing performed for mutations that lead to MH, so most patients do not know they are a carrier
until in an MH crisis.

1.1.3. RyR1 Role in Malignant Hyperthermia and Central Core Disease
Malignant hyperthermia (MH) is an autosomal-dominant inherited disease that manifests as
crises in susceptible individuals.8 Crises occur in between 1:10,000 and 1:250,000 cases of
anesthesia as a result of administration of volatile halogenated anesthetics in susceptible patients,
and these crises may occur at any time between initial administration of the anesthetic and one
hour after termination of the anesthetic dosing.9,10 MH presents with a multitude of the following
symptoms, which can lead to death if not treated immediately: pyrexia, hyperkalemia,
hypercapnia, hypoxemia, cardiac arrhythmia, tachycardia, muscular rigidity, metabolic acidosis,
and late-onset rhabdomyolysis.8,11 The pathophysiological explanation involves structural
changes to the ryanodine receptor 1 (RyR1) that lead to functional changes; specifically, the

5

RyR1 is left constitutionally activated (opened) resulting in the preliminary symptom of muscle
rigidity.12 Fortunately, most operating theaters in the developed world carry dantrolene, a
medication that reverses the symptoms and effects of MH.13
Central core disease (CCD) can be both an autosomal-dominant and autosomal-recessive
inherited disease that affects approximately 1 in 17,000 live births.14,15 Patients with CCD are
more prone to MH and vice versa.16 Patients with dominantly inherited CCD typically present in
infancy with hypotonia and in childhood with muscle stiffness and weakness on exertion as a
result of developmental muscle delay.17 Most patients are able to achieve independence while
walking with the exception of the most severe cases in neonates.18 Once again, the
pathophysiological explanation involves structural changes to the RyR1 that lead to functional
changes; one leading hypothesis is that CCD results from RyR1 adopting a “leaky” conformation
that leads to disruption of muscle contraction.19

1.1.4. Structure and Domains of the RyR1
The cytoplasmic region of the RyR1 has a square face of dimensions 275 x 275 Å2. With the
inclusion of the transmembrane region, the receptor adopts more of a pyramidal shape with a
height of 175 Å. The four subdomains of the receptor can be viewed as triangles forming the
pyramidal quaternary structure. The N-terminal domain is located on the distal portion of the
cytosolic face and is comprised of four domains, one per subunit. Each are divided into three
subdomains of A, B, and C; A and B are predominately beta sheets, whereas C is entirely
comprised of alpha-helices.20

6

Each subunit additionally consists of three SPRY domains; the SPRY1 domain is situated on the
perimeter and serves for FKBP12 binding, the SPRY2 domain is thought to interact with the
Cav1.1 subunits of the DHPR and is located behind the SPRY1 domain, and the SPRY3 domain
is at the most distal cytosolic surface.21,22,23 The function of the SPRY3 domain has not been
biochemically studied, but with its location at the cytosolic face, its function can be speculated as
plausible in the DHPR interaction.24
The handle domain is located at the base of the cytosolic face and creates portions of the binding
sites for FKBP12 and calmodulin. This handle domain is connected to the SPRY2 domain of the
neighboring subunit by the helical domains. These domains have a particular flexibility
associated with them and have been implicated in giving the RyR1 its elasticity and ability to
recoil to different conformations.
The P1 domain of the receptor is at the most distal portion of the clamp domains of the corners
of the ryanodine receptor, and it originates from the SPRY domains.24 The P2 domain contains
phosphorylation site 2808 and 2814 and is suspected to vary immensely based on the
phosphorylation state. As a consequence, the structure has not been resolved except for at a low
resolution.
The central domains are located under the N-terminal domains and behind the handle domains.
They are on the bottom of the cytoplasmic face and interact with the transmembrane region. In
the central domain, two EF hands are present and thought to provide a portion of the Ca2+sensing ability of the RyR1.25 A portion of the central domains comprises a ‘U’ shaped structure
towards the center of the RyR1 called the U-motif. Lastly, the central domains ultimately give
rise to the C-terminal domains, bulky domains at the end of the inner branches, the cytoplasmic
protrusion of the S6 transmembrane helices.

7

The C-terminal domains comprise a portion of the cytoplasmic region of the receptor that alters
in conformation as the ion gate closes in the closed conformation of the receptor.26 The Cterminal domains additionally contain a stabilizing zinc-finger surrounded by the U-motif of the
central domains.
The transmembrane region of the ryanodine receptor contains four transmembrane helices (S1S4) oriented in a helical bundle similar to that of the K+ channel that share similarities to voltagesensing domains in voltage-gated channels.27 Two other helices, S5 and S6, are located in the
transmembrane region; S6 comprises the inner portion of the pore-forming domain, while S5
comprises the outer portion of the pore-forming domain.27,28 The first visualization of these
helices in addition to the S4-S5 link lead to speculation that the RyR1 structure corresponds to
the super family of 6-TM voltage-gated channels for cations, which has been confirmed with the
3.8 Å structure.26,28 The portion of the S6 domain that confers the cytoplasmic/ion gate (Ile4937) is the narrowest portion of the ion pore and corresponds to the location of closing and
opening. The following figure provides a visual depiction of the different domains of the RyR1
based on color (Figure 2).24
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Figure 2. Visualization of the various domains of RyR1 based on color adapted from Samsó et al.
(2017)24

1.1.5. Binding Partners of the RyR1
There exist a variety of small molecules, and their concentrations regulate the conformation of
the RyR1. Ca2+ can influence the conformation of the RyR1 through direct effect in the form of
direct Ca2+ binding or through indirect effect in the form of calmodulin coordination with Ca2+
and binding to the RyR1. Activation of the RyR1 by Ca2+ has a typical bell-shaped profile; that
is, low cytoplasmic [Ca2+] leads to binding at high-affinity Ca2+ sites that activate the RyR1,

9

whereas high cytoplasmic [Ca2+] leads to binding at low-affinity Ca2+ sites that inhibit the
RyR1.29 Simultaneously, increased [Ca2+] in the lumen of the SR has been implicated in
increased sensitivity to [Ca2+] in the cytoplasmic region. The effect of [Ca2+] on the activation of
the RyR1 can be altered by a variety of other reagents including caffeine and ATP. Specifically,
caffeine and ATP increase the sensitivity of the RyR1 to Ca2+ when the SR load is sufficiently
high.30
ATP and other adenine nucleotides activate the RyR1 with the most activating being ATP.31 This
activation is, however, modulated by other small molecules such as Mg2+, Ca2+, and dantrolene.32
ATP, although activating, cannot activate the ryanodine receptor in the presence of Mg2+.33
Cytosolic Mg2+ at a physiological concentration has been shown to inhibit the RyR1, and a
variety of binding sites are implicated. Firstly, Mg2+ acts as a competitive antagonist to the highaffinity Ca2+ site, and secondly, Mg2+ may bind to a low-affinity Ca2+ binding sites that controls
Ca2+ and channel inhibition.29 With regards to the low-affinity Ca2+ binding site, the site is
thought to be a non-specific divalent cation inhibitory site that binds Ca2+ and Mg2+ equally.34
Interestingly, a third effect is observed in the case of the RyR2. Mg2+ was shown to activate the
RyR2 at an intermediate [Ca2+], and this was initially attributed to another cytosolic divalent
cation binding site.35 However, a 2014 paper proposed that cytosolic divalent cation binding site
was located at a pair of cytosolic EF-hand motifs of the RyR2.36 Nonetheless, locating this site or
the non-specific divalent cation inhibitory site will serve to verify one of these model and
provide insight into the emerging role of Mg2+ in MH.37 The following diagram shows the
currently accepted Mg2+ binding sites with their respective KA and KD as well as the ATP
binding site (Figure 3).38
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Figure 3. Accepted Mg2+ and ATP binding sites of the RyR1 adapted from Smith et al. (1986)38
The role of Mg2+ in MH has been studied, but recent years have revealed more insight into the
relationship. Specifically, a pig model of MH has suggested that the primary dependence of that
instance of MH was due to reduced Mg2+ inhibition of the channel.37 Subsequently, a human
model showed that reduced Mg2+ regulation could cause MH.39 Furthermore, it was observed in
2017 that dantrolene treatment of MH requires the presence of Mg2+ in order to be effective in
isolated muscle fibers. 1 mM levels of Mg2+ were unable to reduce halothane-induced Ca2+
waves; however, increasing the [Mg2+] to 1.5 mM returned dantrolene’s ability to decrease the
extent of anomalous Ca2+ waves. The mechanism of action of dantrolene was previously
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unknown, but with this new information, the mechanism is speculated to be through increasing
the Mg2+ affinity of the RyR1.40
There are additionally two proteins that serve as major binding partners for the RyR1, and those
are FKBP12 and calmodulin. FKBP12, also known as calstabin 1, associates with each of the
four subunits of the ryanodine receptor and typically co-purifies with RyR1.41 When bound to
RyR1, FKBP12 is thought to stabilize the closed configuration under physiological conditions.42
Without FBKP12 present, the receptor has a higher probability of being found in the open
configuration, and the interaction with the ß-subunit of the CaV1.1 (DHPR) is destabilized.43
Another binding partner also involved in regulation of the RyR1 is calmodulin (CaM). CaM
contains four EF-hand motifs that alter CaM between CaCaM and apoCaM. Both forms of CaM
bind with stoichiometry of one CaM to each subunit of the RyR1.44 The two forms of CaM act as
a Ca2+ sensor; CaCaM inhibits the RyR1 and SR Ca2+ release, whereas apoCaM has been shown
to be a partial agonist to RyR1 and SR Ca2+ release.45
With all these regulators having conformational effects, studying the structure ofryanodine
receptor is vital to its understanding. However despite significant effort, successful
crystallization of an entire isoform of the ryanodine receptor has yet to occur. Currently, the
closest any group has gotten to atomic resolution of the ryanodine receptor has been as a result of
cryo-electron microscopy; in 2015, the structure of RyR1 was attained to an overall atomic
resolution of 3.8 Å.21 Recent successes of nanodiscs in cryo-EM with membrane proteins and
single-particle reconstructions may be a means of improving this resolution past 3.8 Å.46
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1.2. Nanodiscs:
1.2.1. Introduction to Nanodiscs
Nanodiscs are small phospholipid bilayers that are able to self-assemble and solubilize
membrane proteins by stabilizing the lipophilic transmembrane domain of the protein. An
amphipathic, helical protein termed membrane scaffold protein (MSP) is incubated with a
phospholipid for a preset duration of time, and the nanodiscs self-assemble when two molecules
of MSP wrap around a cluster of phospholipids to form the final product.46 Verification of the
structure of the nanodiscs has been performed; coarse grain and whole-atom molecular dynamics
led to a thorough characterization of the nanodisc self-assembly,47 and small angle x-ray
scattering revealed that structure of the nanodisc is, in fact, a phospholipid bilayer with MSP
associated at the edge.48 The figure below shows the structure of the nanodisc from the top and
side (Figure 4).49
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Figure 4. Schematic of the structure of a nanodisc adapted from Ritchie et al. (2009)49

1.2.2. Membrane Scaffold Protein
The size of the nanodisc is controlled by the length of the cloned MSP; a variety of commercially
available molecules of MSP exist, and one may be chosen to adequately solubilize the membrane
portion of the protein. One available type of MSP is called MSP1E3D1; it is sold as bacteria in
an agar slab and requires inoculation and purification.50 MSP1E3D1 is a 277 amino acid,
(32,599.98 Da) protein that is similar in sequence to Apolipoprotein A-1 but without the Nterminal domain.48 MSP1E3D1 contains an additional 3 helical segments for increased nanodisc
size, and it yields a nanodisc with diameter of 12.9 nm. The first 21 residues of the protein
correspond to the histidine tag and are cleaved by TEV protease leaving a protein of 255 amino
acids for use in nanodiscs.51

14

1.2.3. Phospholipids for Use in Nanodiscs
One phospholipid available for commercial use is 1-palmitoyl-2-oleoyl-sn-glycero-3phosphocholine, or POPC. It is commercially solubilized in chloroform, so it is not usable at that
stage; it must be diluted and dried with N2 gas before ready to use. The structure of POPC is
shown in the figure below (Figure 5).

Figure 5. Structure of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)

1.2.4. Nanodiscs Formation and Use
The key to successful incorporation of the receptor into nanodiscs of uniform size is optimization
of the phospholipid, MSP, and receptor stoichiometry. One method, based on lipid MSP ratio
studies, to determine the correct stoichiometry is defined in the following relationship: NL • S =
(0.423 • M - 9.75)2 where ‘NL’ represents the number of lipids per nanodisc, ‘S’ represents the
surface area of each molecule of phospholipid, and ‘M’ represents the number of amino acids in
the membrane scaffold protein.49 Using the correct, corresponding values, the total surface area
of the nanodisc may be predicted. Subtracting the size of the receptor, one may determine the
number of POPC needed per two MSP and one RyR1. The ratio is typically expressed as
RyR1:MSP:POPC.
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In practice, the protein may be purified and stored using detergent; when the protein is ready for
study, it may be combined with the self-assembled nanodiscs, and the detergent may be
subsequently removed by dialysis. The removal of the detergent serves two purposes; firstly, it
returns the protein into an environment more similar to in vivo, and secondly, it diminishes the
undesirable effects of the detergent such as absorbance, light scattering, and electron scattering.46
This proves particularly valuable for cryo-electron microscopy as the electron scattering
properties of the detergent may negatively impact the contrast of the electron microscopic image
as well as the spread of a sample along the support.52
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1.3. Introduction to Cryo-Electron Microscopy
1.3.1. Factors Affecting Grid Preparation for Cryo-Electron Microscopy
Once the protein has been introduced into nanodiscs, the sample can be combined with other
buffers and reagents to change the configuration. This is of tremendous value as one is able to
alter buffer conditions to reflect certain in vivo situations. As one basic example in context of the
RyR1, one may alter the buffer of the channel to reflect a open or closed state in order to assess
the protein in that specific environment. The sample is then pipetted onto a Quantifoil grid; this
grid consists of a carbon or gold support with square shaped holes with each hole covered by a
smaller carbon or gold mesh containing minute holes. The grid is blotted to absorb most of the
sample, leaving a thin layer of liquid suspended in each of the holes of the holey mesh held by
surface tension. The grid is then flash frozen by plunging into liquid ethane cooled by liquid
nitrogen; the liquid ethane has a higher heat capacity than liquid nitrogen leading to fast-freezing
to vitreous ice and avoidance of crystalline ice formation.
At this stage, a magnitude of different parameters can be changed to alter the resulting cryogenic
grid. For one example, the grid may be initially pre-coated with thin carbon to provide a binding
scaffold over the holes to localize more sample to that region when the sample is of low
concentration. The grid may then also be glow discharged in an effort to increase the
hydrophilicity of the grid for sample pipetting. Even another step prior to plunge-freezing could
be to pre-saturate with sample in an effort to saturate a large percentage of the non-specific
binding sites on the thick carbon scaffolding surrounding the holes.52 Furthermore, prior to the
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plunge freezing one may alter the temperature settings, regulate the humidity of the chamber, and
control the blotting force and blotting time.52 These parameters can both directly and indirectly
alter the thickness of the vitreous ice covering the holes in the support film, and the resulting
thickness may vary between a few hundred angstroms to a few thousand.53 The degree of
thickness will ultimately be a deciding factor in the highest resolution achieved by the
subsequent data processing. Immediately after freezing, the grid may be visualized or stored at
liquid nitrogen temperatures.

1.3.2. Technological Advancements in Cryo-EM
Single-particle cryo-electron microscopy has been dramatically advancing in the past decade to
the point where the technology has resulted in direct electron detectors (DEDs), gold grids, and
electron microscopes the size of a room; however, the technology is still developing. The current
electron microscopes receive their radiation source from a variety of electron guns. The three
main types of electron guns are as follows: a tungsten tipped filament, a lanthanum hexaboride
(LaB6) tipped filament, and a tungsten field emission gun (FEG). The tungsten tipped filament
and LaB6 tipped filament are thermal filaments that, when heated, expel electrons. The
lanthanum hexaboride filament has a lower work function relative to the heated tungsten
filament, and consequently, it is more efficient.54 The most commonly used electron source is the
FEG gun because of its high signal to noise ratio and spatial resolution, and it was the first
electron source for cryo-EM that achieved a structure below 10 Å.55 The smaller source size,
better beam convergence, and increased brilliance provide a better input to achieve higher
resolution structures.56
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The electrons of the source are accelerated with a voltage varying between 200 and 300 kV for
the case of cryo-electron microscopy. The accelerated electrons then pass down the column and
through the sample, while they are focused by electromagnetic lenses onto a form of detector.53
The wavelength of 0.02 Å achieved from a 300 kV voltage source passing to the detector does
not currently serve as a resolution limit for electron microscopy as no cryo-EM structures have
reached a resolution that low; the limitations arise from factors such as the pixel size of the
detector, the levels of background noise, and the fact that electromagnetic lenses are not
perfect.53 Until as recently as 2011, the most conventional methods of data collection have been
CCD detectors and photographic film.57 Although convenient, CCD detectors have lower
detective quantum efficiency and, consequently, lower resolution capabilities than film, and
despite smaller pixel sizes of CCD detectors, resolution limits have not improved.58 Since the
first 3-D reconstruction achieving atomic resolution in 2011, direct electron detectors have
shown much promise.59 The current electron detectors use monolithic active pixel sensors
(MAPS); here, the electrons impact the sensors and pass through semi-conducting membranes,
where they are detected by electronic devices.60 The most current direct electron detectors
available for commercial purchasing are the Falcon II and Falcon 3ec from FEI, the K2 Summit
from Gatan, and the DE-64 from Direct Electron. As the Falcon 3ec has just been recently
introduced to the market, studies have not yet indicated its effectiveness relative to the others.
Nonetheless, a 2015 publication regarding the tobacco mosaic virus compared the Falcon II with
the K2 Summit using the same microscope with substitutions of the different detector. They
found no difference in the resulting resolution or the number of particles required to achieve that
high resolution.61 Taken in context, both can achieve desired atomic resolution; however, the K2
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summit has the capability to detect electrons below the pixel size limitation due to its superresolution capacity.

1.3.3. Radiation Damage from Electron Dosing
When a cryogenic grid is visualized, the grid is exposed to a low dose of electrons that are
received by a detector or camera on the other side of the sample. The extent of radiation that
results is due to the electron dose, that is the electrons per square Ångstrom.62 As the
magnification increases, the electron dose increases as a consequence, and the sample is exposed
to more electrons. To minimize radiation, the sample search is carried out at lower
magnification, which supplies the grid with little radiation. The focus and exposure features
supply a significantly larger amount of radiation, so as a precaution, the focus step is done on a
region adjacent to the area to be exposed. In that way, the exposure is the first large dose of
radiation that the specimen is receiving. The damage that results is due to the inelastic collisions
of the electrons with the specimen that results in changes at the chemical and physical level.62
Disulfide bonds are easily the most susceptible to radiation damage as they face the possibility of
reduction. In addition, aspartate and glutamate residues also possess a rather large chance of
decarboxylation.63 This illustrates two very different examples of radiation damage; one results
from reducing radicals, while the other results from oxidizing radicals.
Although unresolvable, attempts have been made to limit resolution problems resulting from
macro level radiation damage; one of the main practices is to collect data as a movie. For
example, forty frames of an electron micrograph may be collected over the course of a short time
interval in order to take into account any observable movement resulting from ice deformation or
particle movement.64 Using software like MotionCor2 or Unblur, movement vectors for entire
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micrographs and for local areas can be determined and used to align frames or particles.65
Although an essential tool, this correction does not correct chemical changes or particle
movement that does not result from electron beam irradiation; instead, one may take an alternate
approach of masking specific subdomains on the particle of interest that are known to move little
relative to more susceptible regions.
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1.4. Image Processing
1.4.1. Pre-Image Processing: Gain and Motion Correction
The software MotionCor2 has several features other than frame/particle alignment that make it
that more invaluable.66 For example, a gain reference can be subtracted from each of the
micrographs undergoing motion correction in order to take away the background signal from the
detector. Other features available in the software include binning, dose weighting, and frame
removal.66 Binning serves to combine signal from adjacent pixels, which ultimately increases
signal-to-noise ratio. Dose weighting takes into expectations of radiation damage at certain
voltage, pixel size, and electron dose and attempts to correct for them; however, the micrograph
resolution is often compromised as a result. To address this negative consequence, the output is
two summed images, one with and one without dose-weighting so that the experimenter may
choose. Lastly, one is able to remove frames towards the end or towards the beginning of the
movie file. This is particularly advantageous as these are the frames that tend to suffer from
radiation damage the most; particularly, the first few frames tend to suffer more from more rapid
particle movement, whereas the last few frames may have more macro changes such as ice
breaking and protein degeneration.

1.4.2. Pre-Image Processing: CTF correction
The next step following gain correction and motion correction is contrast transfer function (CTF)
determination. Although it is not essential at this stage, certain softwares, specifically Relion,
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require CTF files present from which it acquires certain inputted microscope parameters (such as
pixel size or voltage). The contrast function is defined as follows:
CTF s = − 1 − 𝐴* ∙ sin(𝛾 s ) − 𝐴 ∙ cos 𝛾 s

= − sin(∆∅ + 𝛾 s )

In the above equation, s refers to the spatial frequency, A refers to the amplitude contrast, 𝛾 s
represents the varying CTF phase, and ∆∅ is a global phase shift as a function of amplitude
contrast.67 The contrast transfer function is essentially a quasi-periodic sine function dependent
on mostly the defocus setting; it mathematically describes defects in the collected micrographs.68
The quasi-periodic sine function is visualized by plotting the contrast as a function of the spatial
frequency. Higher amplitudes of the CTF (positive or negative) contain high resolution
information while the zero values contain no information. Additionally, higher levels of defocus
will result in an increased contrast but lower resolution, and lower levels of defocus will result in
a decreased contrast but higher resolution.69 In an effort to find a compromise between the two,
one typically collects images throughout a range of defoci; an example of this is depicted below
(Figure 6).70

Figure 6. Example of CTF curve with multiple defoci adapted from Ranson et al. (2010)70

23

Of note, the y-axis in this figure is labeled as ‘information’ for clarity, but this is more accurately
represented by the label ‘contrast’ or ‘signal-to-noise ratio’ since information cannot be negative.
As indicated by the diagram, changing the values of defoci varies the location in which the
spatial frequency intersects the x-axis and, as a result, has zero information. By doing so, the
areas where the ‘information’ is zero for a given defocus value may differ from the areas where
the ‘information’ is zero for another defocus value. Thus if done correctly, the use of different
defoci should result in information being present at almost all spatial frequencies. Nonetheless,
this is not a perfect system, and sometimes, the different defoci may all have a specific spatial
frequency of zero as represented by the white arrow in Figure 6. In this case, the main solution is
to collect more images at different defoci to hopefully acquire information at that spatial
frequency.
The values of the CTF curves are transformed into Fourier space and the amplitudes are squared
to create a power spectrum of each micrograph. The power spectra may then be transformed
through rotational averaging to depict the signal-to-noise ratio as a function of spatial frequency.
The outcome of these two operations is shown in the figure below with the left panel depicting
the power spectrum and the right depicting the rotational average of the power spectrum (Figure
7).71,72
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Figure 7. Transformation of CTF into Fourier space adapted from McMullan et al. (2014) and Li
et al. (2013)71,72
The image on the left shows the power spectrum resulting from transformation of that CTF in
Fourier space. The rings shown on the right image are called Thon rings; these are a result of the
transformation in Fourier space and provide a more complete visualization of the regions with
and regions without information. The white rings in Fourier space correspond to regions of
information and the black to regions without information. The center corresponds to low
resolution information, and the further the rings expand outwards, the higher the resolution
information contained in the initial corresponding micrograph. The figure on the right reflects the
pattern of the Thon rings such that the white rings on the left figure correspond to the non-zero
values of SNR and the black rings on the left figure correspond to zero values of SNR. The green
circle on the left figure and the green line on the right figure depict the area where the Thon rings
no longer appear, and that is the resolution limit.
These power spectra may be determined using a multitude of computer softwares including Gctf,
ctffind3, and ctftilt. For CTF correction, the power spectra are then matched with Thon rings
from standards of different defoci to predict each micrograph’s true defocus. The determined

25

defoci values will then be used in 3D reconstructions and refinements to improve the resolution
through averaging of information from the non-zero regions of the CTF rather than accidental
averaging of noise. In addition, the Fourier transformation can visually depict other anomalies
including astigmatism, crystalline ice, and drift. Although these may not be corrected through
CTF corrections, the information may be used for decisions regarding discarding bad
micrographs.

1.4.3. Image Processing: Particle Picking and Relion
Following the pre-processing, the micrographs are introduced into a variety of softwares for
particle picking and subsequent steps. The pathways diverge based on personal preferences and
even computational power, so the following discussion will diverge to reflect the two routes.
EMAN2 is written in C+++ and is able to take a microscopy data set to a 3D reconstruction
beyond 10 Å.73 It offers a user-friendly GUI software, Boxer, for particle picking that allows
easy importation into other softwares such as Relion and Spider. A relatively small amount of
particles may be picked and their coordinates submitted for 2D classification in Relion. The
preliminary 2D classification provides references for an autopicking algorithm in Relion.74 The
autopicking selects particles on the already selected micrographs and the remainder of the
micrographs. The resulting particles may be resubmitted for 2D classifications and the bad
classes removed until the data set is considered polished. Or, one may manually deselect the bad
particles and select any particles missed by the autopick. In either route, these particles should be
submitted for 3D classification to generate classes for user analysis. From these classes, the user
may remove any particles that may be in an alternate conformation than the major or desired
conformation.
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The selected class can then be submitted for 3D refinement; this method splits the data into two
halves, creating a volume for each half and generating correlation coefficients for the two
volumes. The result is a Fourier shell correlation (FSC) curve.75 Different criteria are used for
selecting the final resolution. The most common practice is to select the resolution at the spatial
frequency where the FSC curve has a value of 0.5, but other choices of value are used. For
instance, a value of 0.33 corresponding to a SNR of 1.0 and a value of 0.143 derived from a
value used in X-ray crystallography are also used in practice.76 Below is an example of
resolution determination using a FSC value of 0.5 (Figure 8).77

Figure 8. Example of resolution determination using an FSC value of 0.5 adapted from Maurer et
al. (2012)77

1.4.4. Image Processing: Spider and Frealign
Another alternate route is through spider and, subsequently Frealign since Frealign only has 3D
reconstruction capabilities.78,79 Following the boxer particle picking stages, the coordinates are
brought to Spider, re-centered, and extracted from the original micrographs (in spider format).
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The extracted particles may then go through two different routes. Firstly, the particles may be
inverted and compared to a reference in a variety of different rotations for 2D classification. This
differs from the Relion software in multiple aspects. Firstly, Relion provides unbiased, referencefree classifications that minimizes noise fitting; however, the different angles of the references
provide for better classification as each particle is compared to all the specified angles of the
reference that takes place in spider. This classification proves useful if the particles selected may
be verified as actual particles rather than non-particles, but if this is not the case, the “Einstein
from noise phenomenon” may occur. This occurs when random, pure noise is fit into the given
references and averaged; the resulting images tend to look like the reference but only because the
chosen features from the noise are averaged to look like the references.80
Although useful, these 2D projections are not necessary for 3D reconstruction of the data set.
Instead, the particles may be submitted to the 3D as either a stack for Spider or as document file
referencing the actual particles for Relion. Both softwares have relatively similar capacities;
Spider is able to perform 3D classifications and 3D refinements, and Relion is able to do the
same. The 3D classification serves as a means of separating particles belonging to different
conformations. For example, if a channel such as the RyR1 is in a conformation between open or
closed or is in a minority conformation, those particles may be classified separately and removed
from the stack or reference file to leave only all the particles of the desired conformation. These
particles can be submitted for 3D refinement, and the 3D structure based on the input particles
will be refined until no resolution improvements occur.

1.4.5. Post-Image Processing: Rosetta and Phenix for Map Building
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Once a sufficient resolution is achieved, the volume can be submitted to a model building
software such as Phenix or Rosetta. Rosetta has a variety of functions for model building, but the
de novo structure prediction algorithm serves as a good map building software.81 Specifically,
Rosetta inserts backbone fragments using low-resolution energy function and sampling
approaching to survey for proper fitting. An atomic-detail refinement mode is available that may
bring the structure to the best match of each atom to the volume. Rosetta additionally offers the
ability for the user to fit some portions of the structure as an initial guideline for the software to
align the structure.

29

1.5. Future of Cryo-Electron Microscopy: Increasing Use and Applications
The incidence of determined cryo-EM structures has increased exponentially since 2010 and
membrane proteins comprise a higher percentage of the structures determined by cryo-EM than
they do for NMR or X-ray crystallography; this is depicted in the figure below (Figure 9).82

Figure 9. Growing incidence of electron microscopy for structure determination adapted from
Fernandez-Leiro et al. (2016)82
With structures reaching ~3.0 Å resolution from cryo-EM, it is becoming a real contender to Xray crystallography. This year (2017), the average resolution for structures desposited in the
EMDataBank from single particle cryo-EM was 7.9 Å; this is the first year that this average has
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fallen below 10 Å, and the trends of resolution for this year and previous are displayed in the
figure below (Figure 10).83

Figure 10. Resolution trends of single-particle structures deposited in EMDataBank adapted from
Lawson et al. (2016)83
Lastly, the result from cryo-EM is not binary; that is, low resolution volumes resulting from
cryo-EM still result in an informative result, whereas X-ray crystallography depends entirely on
successful crystallization of a protein.84 With the growing incidence of cryo-EM facilities,
protocol changes to effectively increase resolution, and improving technologies, cryo-EM will
eventually achieve resolutions below 3.0 Å. In addition, cryo-EM will prove invaluable as it
progresses because it provides more natural protein environments than crystals and allows the
user to manipulate the state through altering of buffer conditions.
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1.6. Goals and Aim of Study
The initial goal of the study was to insert the RyR1 into nanodiscs for a number of reasons.
Firstly, the nanodisc will return the RyR1 from a detergent environment to a more native
membrane environment. Secondly, the lack of detergent will theoretically improve the resolution
of the images collected during a subsequent cryo-electron microscopy phase.
Following preliminary verification of successful incorporation of the RyR1 into nanodiscs, the
aim of the study was to assess the conformation of the ryanodine receptor from skeletal muscle
(RyR1) in response to additions of Mg2+ and AMP-PCP using single-particle cryo-electron
microscopy and subsequent 3D reconstruction. These additions serve to mimic resting
physiological conditions with AMP-PCP replacing ATP because it is a non-hydrolyzable analog.
Since ATP is activating and Mg2+ is inhibiting, the expected conformation is not perfectly clear;
however, it is postulated that the channel will be closed as it is closed in resting physiological
conditions. The resulting closed model of RyR1 is expected to serve as a more accurate depiction
of the true closed state of the RyR1 because it is the result of buffer conditions more similar to
the cell contents that the RyR1 would experience in vivo.
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2. Methods

2.1. Purifications
2.1.1. Rabbit Tissue Extraction and Sarcoplasmic Reticulum Vesicle Isolation
A rabbit is anesthetized with a mixture of ketamine, xylazine, and acepromazine; the dosing for
each of these is 35 - 50 mg/kg, 5 - 10 mg/kg, and 0.75 - 1.0 mg/kg, respectively. When the rabbit
does not respond to pinching, its heart is removed, and it is exsanguinated. The rabbit’s body is
placed on ice and the skin removed from the rabbit. The back muscle and the muscle from the
hind legs is removed from the rabbit, cut into one inch by one inch pieces, and flash-frozen in
liquid nitrogen. When ready for use, 130.0 g of frozen tissue is weighed and pounded with a
hammer until broken into small pieces. The muscle is homogenized in a commercial blender
with 170 mL of 0.3 M sucrose and 5 mM imidazole-HCl buffer at pH 7.4 per 50.0 g of tissue, in
this case 442 mL. The homogenization is done for three 30 second intervals with 20 second
intervals in between. The homogenate is centrifuged at 8000 rpm using a 510BCl-500γ rotor for
21 minutes. The supernatant is discharged, and the pellet containing the SR vesicles is
resuspended in a commercial blender with fresh 170 mL of 0.3 M sucrose and 5 mM imidazoleHCl buffer at pH 7.4 in the same manner as described previously.
The rehomogenates are centrifuged at 8000 rpm using a 510BCl-500γ rotor for 27 minutes; in
this instance, the soft pellet is discarded by passing the supernatant is passed through 8 layers of
cheese cloth. The filtered homogenate is centrifuged at 43,5000 rpm in a Beckman Ti 45 rotor
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(220,000 g) for 50 minutes to pellet the SR vesicles. The resulting pellet is suspended in 0.3 M
sucrose and 5 mM imidazole-HCl buffer at pH 7.4 at a ratio of 1.5 to 2.0 mL per 250 mL
equivalent of filtered homogenate. The resuspension is aliquoted into 500 µL fractions and flashfrozen in liquid nitrogen for storage at -80ºC.
The concentration of the vesicles is determined by a Bradford method. Standards of BSA diluted
to concentrations of 0.01, 0.03, 0.05, 0.07, and 0.09 mg/mL with water are mixed with equal
parts Bradford reagent, and the absorbance is measured at 595 nm to generate corresponding data
points. A standard curve best representing the acquired data points is determined with a linear or
logarithmic fitting software in Microsoft Excel; an R2 value of 0.95 or higher is considered
adequate to use for concentration determination. The vesicles are diluted in water to a
concentration between 0.01 and 0.09 mg/mL and combined with equal parts Bradford reagent.
The absorbance at 595 nm is determined and used in the equation generated from the BSA
standards to give a value of concentration for the vesicles.

2.1.2. RyR1 Isolation from Sarcoplasmic Reticulum Vesicles
Approximately 70 mg of vesicles are thawed in a 37ºC heating block and placed on ice. Buffer
stocks are added in the following order to attain the following concentrations: water, 1M NaCl,
20 mM MOPS, 2 mM DTT, 0.025 mg/mL aprotinin and 0.025 mg/mL leupeptin and 0.0125
mg/mL pefabloc SC as a cocktail, vesicles, and 8.8% CHAPS with 0.6% phosphatidylcholine
(PC) as a cocktail. The mixture is stirred vigorously on ice for 15 minutes until the solution no
longer appears turbid, and the SR vesicles are solubilized. The solution is centrifuged at 43,000
rpm in a TLA 100.3 (100,000 g) for 60 minutes, and the pellet is discarded. Approximately 3 mL
of the solution is loaded into a 34 mL discontinuous sucrose gradient consisting of 5 mL 20%
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sucrose, 6 mL 18% sucrose, 6mL 16% sucrose, 6 mL 14% sucrose, 6 mL 12% sucrose, and 5 mL
10% sucrose with a peristatic pump. The gradient is centrifuged at 27,000 rpm using a SW32
rotor (141,000 g) at 4ºC with low braking and low acceleration for 18 to 24 hours to separate the
RyR1 from contaminant proteins. The gradient is unmounted from the top and collected in 1.5 to
2 mL fractions. Every other fraction is ran combined with 2 equivalents of 3X SDS loading
buffer (containing ß-mercaptoethanol) on a 12.5% SDS-PAGE gel to check the location of the
RyR1 at 80-120 V until the gel front runs off, approximately an hour to an hour and a half. The
gels are stained with coomassie blue and the peak fractions containing RyR1 pooled.
The peak fractions are diluted 5 fold in buffer to a final concentration of 20 mM Na-MOPS at pH
7.4, 0.5% CHAPS, 2 mM DTT, and 0.025 mg/mL aprotinin and 0.025 mg/mL leupeptin and
0.0125 mg/mL pefabloc SC as a protease inhibitor cocktail. A 1 mL prepacked HiTrap Heparin
column is prepared with filtered water followed by 10 mL of equilibration buffer consisting of
0.2 M NaCl, 20 mM Na-MOPS at pH 7.4, 0.50% CHAPS, 2 mM DTT, and 0.025 mg/mL
aprotinin and 0.025 mg/mL leupeptin and 0.0125 mg/mL pefabloc SC as a protease inhibitor
cocktail at a rate of 1 mL/min. The diluted fractions are loaded at a speed of 0.5 mL/min
overnight, and the column is then washed with mL of the equilibration buffer. The RyR1 is
eluted with an elution buffer consisting of 0.9 M NaCl, 20 mM Na-MOPS at pH 7.4, 0.50%
CHAPS, and 0.025 mg/mL aprotinin and 0.025 mg/mL leupeptin and 0.0125 mg/mL pefabloc
SC as a protease inhibitor cocktail, and it is collected in fractions of 150 µL fractions. The
Heparin column serves to concentrate the RyR1 into peak fractions. 5 µL of each fraction is
combined with 10 µL of Bradford reagent on a piece of Parafilm assess the peak of the elution.
The peak elution fractions are pooled, and the subsequent fractions are also pooled in a separate
tube. Each pooled fraction is then assessed for protein concentration by the Bradford method
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described above. The pooled fractions are then aliquoted into 15 µL aliquots and frozen in liquid
nitrogen; these fractions are labeled and stored at -85ºC. 5 µL of the fractions is saved for
negative staining.
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2.2. Negative Stain: Assessing the Quality of the Purified Ryanodine Receptor
A carbon film-coated grid is glow-discharged with 25 mA for 25 seconds. 5 µL of sample from
the peak fraction is pipetted onto the carbon film-coated grid and allowed to incubate for 60
seconds. The liquid is then blotted with filter paper. The grid is then washed twice with water for
2 seconds with blotting following each rinse. The grid is then washed once with 0.75% uranyl
formate for 2 seconds, blotted with filter paper, washed again with 0.75% uranyl formate for 20
seconds, and blotted for a final time. The grid is then stored until visualization is desired. When
ready for visualization, the grid is loaded into a TEM Tecnai F20 and images are collected with a
defocus range of 1.0 µm to 2.0 µm. These images are used to assess the quality of the ryanodine
receptor.
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2.3. Nanodiscs: Formation
When the sample is ready to be solubilized into nanodiscs, the 15 µL fractions are thawed in a
37ºC heating block until no ice is present. The ratio of RyR1 to MSP to POPC is calculated using
the equation NL S = (0.423M - 9.75)2, where NL is the number of molecules of phospholipid
(POPC), S is the surface area of the phospholipid, and M is the number of residues in the
molecule of MSP. A variety of ratios close to the calculated ratio are empirically tested to
ultimately determine the best ratio by visual interpretation through electron microscopy. The
POPC is prepared by taking 5 µL of POPC stock in chloroform, drying it with N2 gas, and
diluting it 20 fold in buffer to final concentrations of 20 mM Na-MOPS at pH 7.4, 900 mM
NaCl, 2 mM DTT, and 0.5% CHAPS. The appropriate amount of this buffer is added to the
microcentrifuge tube to reach the desired volume followed by the determined amounts of POPC,
MSP, and then RyR1 to reach the desired ratio and concentrations. The solution is allowed to
incubate on ice for 90 minutes to allow for formation of the nanodiscs.
After incubation, 60 µL of the nanodisc mixture is pipetted into a 50 µL dialysis button to form a
liquid dome at the dialysis interface. A dialysis membrane with a molecular weight cutoff of
6,000 to 8,000 is placed over the opening of the button, and a rubber O-ring is used to fasten the
membrane into place. The dialysis buttons are placed into 250 mL of dialysis buffer consisting of
20 mM Na-MOPS at a pH of 7.4, 855 mM NaCl, and 2 mM DTT. The buffer is replaced after 4
hours and then allowed to continue dialyzing overnight in fresh buffer. The button is then
removed from the buffer and the membrane cut with a razor blade. The 50 µL of nanodisc
solution remaining in the button is extracted with a pipette and placed on ice. 5 µL of the
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nanodisc solution is stained with uranyl formate as described previously to ensure that the
ryanodine receptor still has its structural integrity.
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2.4. Cryo-Electron Microscopy Protocol
2.4.1. Grid Preparation Protocol for Cryo-Electron Microscopy
The RyR1 nanodiscs are combined with buffers to a final concentration of 2 mM EGTA, 5 mM
AMP-PCP, 2 mM Mg2+, 20 mM MOPS, 1.2 mM DTT, 500 mM NaCl; there is no detergent
remaining in solution following dialysis. The sample is ready for freezing at this stage. Four to
eight Quantifoil grids are washed in water, then acetone, then isopropanol, then chloroform. The
grids are glow discharged at 15 mA or 25 mA for 25 seconds. 3.5 µL of sample is pipetted onto
the grid and allowed to incubate for 60 seconds as a pre-saturation method. The grid is then
blotted using filter paper and pressure applied with the fingers. The grid is loaded into the
Vitrobot with varying blot force, blot time, and temperature, and it is then plunge frozen into
liquid ethane. The grid is then transferred to liquid nitrogen for storage.

2.4.2. Micrograph Acquisition
When ready to be visualized, the grid is placed on the pre-cooled holder and loaded into the
Tecnai F20 with a CCD camera. Images are collected with a defocus range of 1.5 µm to 3 µm,
and these images are used to assess the quality of the vitreous ice and the ryanodine receptor.
Once the sample contains a sufficient concentration and quality, the remaining grids are loaded
into a Titan Krios with a K2 summit direct electron detector, and images collected with a defocus
range of 1.0 µm to 2.0 µm to attain a thorough data set. The magnification is set to 105,000
resulting in a pixel size of 1.39 Å with a super resolution of 0.7 Å. The targeted total dose is set
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to 40 electrons/Å2 with a targeted dose rate of 1-8 electrons/pixel/second and a dose per frame of
1-2 electrons/frame. The images are saved in movie format (40 frames) without the gain
reference subtracted.

2.4.3. Image Processing Protocol
The images were unzipped to a computer containing a Linux based operating system, and the
gain reference is rotated 270 degrees and subtracted from each image through the software
Motioncorr2. Simultaneously, Motioncorr2 corrects for motion of each 5x5 patch and truncates
the first two and last three frames of the movie files. CTFFIND3 and GCTF are used to
determine the actual defocus values for later correction. Particles are picked on the first half of
the micrographs using the software Boxer by EMAN2. These particles are provided to the
software Relion, where they are extracted and sent for 2D classification into 50 classes. The
classes are assessed and selected to be given as references for autopicking. Autopicking is
performed on the remaining micrographs, 1041 through 2083. These picked particles are all
visualized using Relion, and the non-particles (false positives) selected by the autopick algorithm
are manually removed. The particles are then combined with the particles picked from Boxer and
sent again for 2D classification of 50 classes. The particles from the best classes are selected for
3D classification with 2 different classes. Simultaneously, the combined particles are sent to
Spider for a reference-based 2D classification. The particles are also stacked using Relion, and
sent to Frealign for 3D classification as well.
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3. Results

3.1. Protein Purification Results
3.1.1. Sarcoplasmic Reticulum Vesicle Concentration Determination
Sarcoplasmic reticulum vesicles were purified using the protocol described above, and the
concentration of the resulting vesicles was determined using the Bradford assay described above.
Figure 11 below serves as an example for the resulting Bradford standard used to determine the
concentration of the SR vesicles.

Figure 11. Absorbance at 595 nm as a function of [BSA] to generate a standard curve to
determine sarcoplasmic reticulum vesicle concentration following tissue extraction.
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In this particular incidence, the concentration of the protein present in the SR vesicles was
determined to be 54 mg/mL from an absorbance value of 0.466 at 595 nm from the 10,000-fold
diluted sample (Figure 11). Ranges of concentrations varied from approximately 25 mg/mL to 60
mg/mL based on the amount of buffer used to solubilize the pelleted vesicle fraction. The
determined concentration is then used to assess the amount of CHAPS for adequate
solubilization.

3.1.2. Sucrose Gradient Separation
Following vesicle purification and sucrose gradient separation, fractions from deconstructed
sucrose gradients are ran on an SDS-PAGE gel; an example gel is shown below (Figure 12). The
gel is used as an analytical method in order to determine the purest fractions to be pooled for
concentrating with a Heparin column.
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Figure 12. SDS-PAGE gel consisting of fractions from a sucrose gradient used in RyR1
purification from sarcoplasmic reticulum vesicles

3.1.3. RyR1 Concentration Determination
At the end of purification, the concentration of the protein is determined in order to properly
optimize the ratio needed for formation of nanodiscs; below is an example of the Bradford assay
and standard used to determine the protein concentration (Figure 13).
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Figure 13. Absorbance at 595 nm as a function of [BSA] to generate a standard curve to
determine protein concentration following RyR1 purification
In this particular incidence, the concentration of the vesicles was determined to be 1.5 mg/mL
from an absorbance value of 0.433 at 595 nm from the 100-fold diluted sample. Throughout
different purifications, ranges of concentrations of RyR1 varied from approximately 0.5 mg/mL
to 5 mg/mL. Using this value, a given concentration of protein may be accurately used, and the
desired ratio of MSP and POPC for formation of nanodiscs may be properly achieved.
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3.2. Incorporation of RyR1 into Nanodiscs Results
3.2.1. Determination of Optimal Ratio
N7 ∙ S = (0.423 ∙ M − 9.75)*
A value of 255 for ‘M,’ corresponding to the number of amino acids in the MSP1E3D protein
following cleavage, is substituted into the equation above. NL • S, or the area of the nanodisc is
determined to be 9626 Å2. Subtracting the area of the transmembrane region of the RyR1, 6400
Å2, the area remaining that needs to be occupied by POPC is determined to be 3226 Å2. Dividing
by a value of 70 Å2 for ‘S,’ corresponding to the surface area of each molecule of POPC, the
number of POPC theoretically needed to solubilize the RyR1 is determined to be 46. Thus, the
calculated theoretical ratio of RyR1:MSP:POPC should be 1:2:46.

3.2.2. Addition of EGTA , Mg2+, and AMP-PCP for Open-State/Physiological Conditions
With careful use of the Ca/Mg/ATP/EGTA Calculator v1 constants from Theo Schoenmakers'
Chelator, the optimal amount of EGTA for addition was determined in order to maintain a
physiological level of Mg2+ while limiting Ca2+ to a resting and minimal level. The following
figure (Figure 14) shows the output from the calculator. 85
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Figure 14. Output from Ca/Mg/ATP/EGTA Calculator v1 Constants from Theo Schoenmakers'
Chelator using values to optimize desired concentrations for cryo-EM adapted from
Schoenmakers et al. (1992)85
The value of 0.007 mM Ca2+ was estimated for the amount of Ca2+ present in the deionized water
used in the laboratory. Using the calculator, it was determined that 0.002 M EGTA will chelate
99.99% of the Ca2+ bound in the water. A value of 5.0 mM Mg2+ will achieve a value of 0.778
mM free Mg2+, which matches the physiological value of 0.7 to 1 mM free Mg2+.86,87 In addition,
these final values will ensure adequate supply of both small molecules so that the receptor may
bind both readily. AMP-PCP, a non-hydrolyzable analog of ATP, is substituted in place for ATP.
The structure of AMP-PCP is depicted below (Figure 15).
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Figure 15. Structure of AMP-PCP, a non-hydrolyzable analog of ATP
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3.3. Negative Stain for Nanodisc Analysis
3.3.1. RyR1 Nanodisc Insertion Confirmation
Following dialysis, no detergent remains in the solution. This would, theoretically, lead to
protein aggregation or degradation if no means of transmembrane stabilization is present. This
gives rise to a preliminary means of conformation that the ryanodine receptor is inserted
nanodisc; if the receptor holds its structural integrity, then the receptor is likely stabilized by the
nanodisc. Below is an example of negative stained micrographs before and after nanodisc
solubilization at the ratio of RyR:MSP:POPC as 1:2:36. (Figure 16)

Figure 16. Comparison of pre and post nanodisc treatment
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In both the image on the left and the image on the right, the receptor retains its square
conformation and structural integrity; since the image on the right is without detergent, it appears
the nanodisc successfully stabilized the transmembrane region of the RyR1.

3.3.2. Comparison of RyR1 Nanodisc Ratios 1:2:36, 1:2:50, 1:2:70, and 1:4:72
With the theoretically determined ratio of 1:2:46, four ratios of RyR1:MSP:POPC were elected
for testing and negative staining analysis. These ratios were 1:2:36, 1:2:50, 1:2:70, and 1:4:72.
Selected regions of micrographs from each ratio are displayed in the figure below for comparison
(Figure 17).
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Figure 17. Negative stain depiction of nanodisc ratios (RyR1:MSP:POPC) of 1:2:36, 1:2:50,
1:2:70, and 1:4:72
Both the nanodisc ratios (RyR1:MSP:POPC) of 1:2:36 and 1:2:50 proved sufficient for
solubilizing the RyR1, but the ratio of 1:2:50 agrees more closely with the theoretical ratio and
was elected for use. The ratio of 1:2:70 resulted in large accumulations of lipids, that was
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ultimately undesirable due to the potential light scattering properties, and cryo-EM was not
performed with this ratio. The ratio of 1:4:72 resulted in a superfluous amount of nanodiscs
without RyR1 incorporation and, as a consequence, cryo-EM studies were not performed with
this ratio.

3.3.3. RyR2 Nanodisc Confirmation
The ratio of 1:2:36 was additionally tested on RyR2. The micrograph below depicts a section of
one of the obtained micrographs (Figure 18).

Figure 18. Confirmation of RyR2 insertion into nanodiscs
The molecules of RyR2 appear to retain their structural integrity as indicated by their standard
square shape with an ‘X’ in the middle. This serves as a preliminary validation of successful
insertion of the RyR2 into nanodiscs as all detergent was dialyzed from the sample in a previous
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step. Since the nanodisc remains without detergent, it must be stabilizing the transmembrane
region of the RyR2 leading to retention of structural integrity.

3.3.4. Visualization of the Nanodisc in RyR2
While investigating if the RyR2 could be incorporated into nanodiscs, one particular side view
appeared to show the nanodisc in the transmembrane region the channel (Figure 19).

Figure 19. Negative stain side view seemingly depicting nanodisc insertion
In the above figure, there appears to be an extra density in the transmembrane region of the
channel, and this is thought to be the first direct visualization of the nanodisc.
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3.4. Cryo-EM using Tecnai F20 with a CCD Camera
3.4.1. Effects of low [NaCl]
For preliminary cryo-EM, a nanodisc ratio of 1:2:36 and a [NaCl] of 88 mM was used; the
images below depict representative area of the obtained micrographs (Figure 20).

Figure 20. Cryo-EM of RyR1 at nanodisc ratio of 1:2:36 and [NaCl] of 88 mM
The particles are circled in red for easy recognition. As seen on the left, a portion of the RyR1
appear to be structurally intact and usable for single-particle analysis; however, the majority of
them are not due to incorporation into aggregates. The image on the right depicts one of the
many aggregates among this data set. Due to the very small amount of RyR1 present for singleparticle analysis, the data was not analyzed by 2D or 3D classifications, and a new sample was
attained with different parameters.
54

3.4.2. Observations of Increased [NaCl] and Tilted Images
Following the aggregation seen with a [NaCl] of 88 mM, the [NaCl] was increased to 500 mM,
and a variety of properties including blotting time, blotting force, and blotting temperature were
manipulated to alter the ice conditions from too thin and tearing to slightly thicker and more
stable. Representative areas, one without stage tilt and one with 30º stage tilt, from micrographs
of this data set are displayed below (Figure 21).

Figure 21. Comparison of cryo-EM of RyR1 at [NaCl] of 500 mM without stage tilt and with 30º
stage tilt
The particles are circled in red for easy recognition. The initial data was collected without tilt
and is depicted on the left; aggregates were present to a minimal extent, and the majority of the
particles contained adequate space for picking like those seen above. The image on the right
depicts the same grid preparation but with a stage tilt of 30º. The tilt orients the cytoplasmic
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views in a configuration that exposes portions of the side of the RyR1 as means of trying to
resolve more structure in those regions.

3.4.3. 2D Classification Using Relion without Tilted Images Incorporated
The micrographs without tilt were picked first using Boxer, and the coordinates were imported
into Relion for 2D classification. Following 2D classification, the classes were analyzed, and the
best were selected; the chosen classes for 3D classification are depicted below (Figure 22).

Figure 22. Classes of RyR1 without tilt
The majority of the views are of the cytoplasmic faces (2 and 3) of the RyR1 indicated by the
low level of noise surrounding their 2D averages. The remaining five class averages have
significant background noise but still show features of the RyR1; however, they comprise such a
low percentage of the data set (less than 10%) that it was decided to collect more data with a
stage tilt of 30º and 50º.

3.4.4. Spider and Frealign Classifications with Tilted Images Incorporated
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Following acquisition of the tilted data, additional particles were picked and CTF parameters
were determined using a CTF tilt software. These figures were sent for reference-based 2D
classification using the Spider software, and the class averages are shown below (Figure 23).

Figure 23. 2D class averages of RyR1 with incorporated tilted images using Spider
Analysis of the 2D class averages showed that approximately 9% of the images fell into the last
two class averages (side views, bottom right). Additionally, the first 3 class averages (fourfold/top views, top left) only comprised about 37.5% of the data set indicating that the
distribution is relatively well spread between each of the classes. As a consequence, the decision
was made to send the data to Frealign for 3D refinement without limiting the amount of top
views. The results of the 3D refinement are displayed below (Figure 24).
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Figure 24. 3D density map of RyR1 with Mg2+ and AMP-PCP with tilted images incorporated
The overall resolution achieved was 20.97 Å based on the criteria of a 0.500 value on the Fourier
Shell Correlation (FSC) curve. The presumed limiting factors of reaching the Nyquist limit of
9.32Å is the resulting noise from the thickness of vitreous ice and from the use of a CCD camera
rather than a direct electron detector (DED).
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3.5. Cryo-EM using Titan Krios with a DED
3.5.1. Image Acquisition and Microscope Settings
Using a K2 Summit direct electron detector in super resolution mode with a physical pixel size
of 5 µm, 2083 micrographs were initially obtained. Table 1 describes the microscope settings
used to acquire images.
Table 1. Microscope state for data collection using a direct electron detector
Magnification: 105,000

Image Pixel Size: 0.66 Å

Nominal Dose: 41 e-/Å2

Spot Size: 9

Illuminated Area: 1.11 µm

Exposure Time: 12 sec

Binning: 1

Number of Frames: 40

Settling Time: 15 sec

Defocus Range: -1 to -2 µm

Defocus Step: 0.25 µm

Focus Interval: 6 µm

Following image acquisition, the images were gain corrected and low-pass filtered to 10 Å for
particle picking. An example of a region of an acquired image is depicted below (Figure 25).
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Figure 25. Sample region of micrograph collected with direct electron detector and low-pass
filtered to 10Å
The red circles encapsulate particles from a sample region of the micrograph. As compared to the
previous data collected with a CCD camera, the particles contain significantly more substructure
despite filtering to 10 Å.

3.5.2. 2D and 3D Classification using Relion
Following particle picking on the first 1000 micrographs, autopicking was performed on the
remaining 1083 micrographs, and the autopicked particles were screened for validity, while the
false positives were removed. All 140,220 of the selected particles were imported into Relion for
2D classification in an effort to fully remove the non-particles for 3D classification; below is the
selected classes from 2D classification that were ultimately sent for 3D classification (Figure 26).
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Figure 26. Selected classes from DED micrographs for 3D classification
The majority of the particles fell into the cytoplasmic (face) view category, and the software
began classifying various cytoplasmic views based on defoci. There are 3 instances of noncytoplasmic views in row three, column 10; row 4, column 1; and row 4, column 10. Despite the
excess majority of views corresponding to cytoplasmic views, 3D classification was still
performed on the data set; the 3D structure resulting from classification using Relion is depicted
below (Figure 27).

Figure 27. 3D density map of RyR1 with Mg2+ and AMP-PCP using 3D classification function
of Relion
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The overall resolution achieved from this 3D classification was 9.06 Å based on the criteria of a
0.500 value on the Fourier Shell Correlation (FSC) curve. Of note, the transmembrane helices do
not appear to protrude below the lipid density at the luminal end of the receptor, so this lead to
the decision to use another software for 3D reconstruction.

3.5.3. 2D Classification using Spider
Prior to 3D analysis, the 140,200 selected particles were re-screened to ensure that no particles
were selected on the edge of the micrograph and that all the particles would be compatible with
Frealign. This resulted in 136,586 particles being submitted for 2D classification and class
averaging; the resulting averages are shown below (Figure 28).

Figure 28. 2D class averages from DED micrographs formed using Spider
Analyzing the data, only 0.8% of the particles fell into the last two categories (side views,
bottom right); that corresponds to 1,022 particles, which is even less than the number in the tilted
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particle data set (1,672). Furthermore, 83,209, or approximately 61% of the data set, fell in the
first class alone. As a consequence, it was deemed necessary to acquire more data using tilting of
40º in hopes of acquiring more side views and populating the other 42 classes in Figure 28.

3.5.4. 3D Classification using Frealign
Despite only having 1,022 side views, it was decided to proceed with processing the data in
Frealign in hopes that the structural determination will perform better than Relion. The first class
consisting of 83,209 particles was decreased in size to avoid any generation of artifact. The
particles in this class were sorted in five categories of defoci, and approximately 3,000 particles
from the first four defocus categories (0 µm to 2.5 µm) were selected and approximately 14,000
from the final defocus category (2.5 µm to 3.3 µm) for a total of 26,000 particles. The following
figure depicts the distribution of particles into different orientation groups before and after
removal of the excess (Figure 29).

Figure 29. Distribution of particles in classes before and after data removal
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The resulting data set consisting of 79,457 particles was sent to Frealign for 3D classification
with only one 3D class and subsequent 3D refinement; the result of the refinement is depicted
below (Figure 30).

Figure 30. 3D density map of RyR1 with Mg2+ and AMP-PCP using 3D classification function
of Frealign
Despite only achieving a resolution of 9.06 Å (identical to that of Relion) based on the criteria of
a 0.500 value on the Fourier Shell Correlation (FSC) curve, the structure appears to be better for
a number of reasons. First, the transmembrane helices appear to protrude below the lipid density
at the luminal end of the receptor, unlike the structure from Relion. Additionally, the pore
transcending the length of the receptor has been resolved; of note, this does not speak to the open
or closed state of the receptor, and this will be addressed in later parts of the results and
discussion. Lastly, all three faces of the RyR1, the cytoplasmic, side, and luminal faces, have
more detail resolved than that of the Relion reconstruction. Consequently, this structure was used
for the preliminary 3D analysis shown here until acquisition of tilted data is acquired and
processing is performed.

3.5.5. Depiction of α-helices of RyR1
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As a crude validation of a resolution of 9.06 Å, one may look for α-helices as they are only
visible at resolutions under 10 Å. The figure below provides a view in which one may see αhelices (Figure 31).

Figure 31. Depiction of α-helices in the 3D density map of RyR1 with Mg2+ and AMP-PCP
At the points of each of the four white arrows, the same comb-like pattern of α-helices from each
of the four subunits are visible; these helices serve as validation that the states resolution is at
least below 10 Å.

3.5.6. Analysis of FKBP12
As speculated, FKBP12 was removed during the sucrose gradient separation (Figure 32).
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Figure 32. Depiction of lack of FKBP12 in the 3D density map of RyR1 with Mg2+ and AMPPCP
The white arrows indicate the location of FKBP12 on the near-atomic resolution density map in
red; this corresponds to the PDB ID of 3J8H and will be referenced to as such.21 The density
corresponding to FKBP12 does not appear on the density map of RyR1 with Mg2+ and AMPPCP indicating that it was, in fact, removed during purification during the discontinuous sucrose
gradient.

3.5.7. Depiction of Nanodisc in 3D Reconstruction.
As part of the initial negative staining studies, the goal was to optimize the ratio of
RyR1:MSP:POPC for insertion into nanodiscs. Successful incorporation into nanodiscs was
based on the assumption that the RyR1 was unstable without detergent and that, since detergent
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was not present, the RyR1 had to be inserted into the nanodisc in order to retain its quaternary
structure. Following 3D reconstruction, the transmembrane region may more clearly be
visualized than 2D class averaging and, thus, assessed for the presence of a nanodisc. The
following image shows the 3D reconstruction with Mg2+ and AMP-PCP as compared to the
closed state of the RyR1 at 3.8 Å, 3J8H (Figure 33).21

Figure 33. Depiction of the nanodisc from the side view in the 3D density map of RyR1 with
Mg2+ and AMP-PCP
Firstly, the black arrows of Figure 33 depict the P2 domains of the RyR1 and how they protrude
significantly more from the closed, near-atomic map of 3J8H. The P2 domain is typically a very
unstable domain due to its flexibility, so this protrusion of the domain indicates that it has been
stabilized, possible as a result of the addition of Mg2+ and AMP-PCP.
The extra density of blue indicated by the white arrows surrounding the red density of 3J8H
corresponds to the nanodisc. This serves as validation that the RyR1 was, in fact, inserted into a
nanodisc. It is possible to question why the nanodisc is unable to be visualized through negative

67

stain, and to answer this, one must analyze the nanodisc from the luminal view. The following
figure shows the nanodisc from the luminal view of the RyR1 (Figure 34).

Figure 34. Depiction of the nanodisc from the luminal view in the 3D density map of RyR1 with
Mg2+ and AMP-PCP
As indicated by the white arrows, even the most distal regions of the nanodisc are masked by the
cytosolic face of the RyR1; as a consequence, one is unable to see the nanodisc from the
cytoplasmic view. From the perspective of the luminal view, the nanodisc appears to blend with
the under portion of the cytoplasmic face. Ultimately, the only view in which the nanodisc may
be reliably visualized is the side view, and this, unfortunately, is the least common of the views.
As a result, negative stain serves as a poor visual indicator of nanodisc insertion while 3D
analysis provides more reliable confirmation.

3.5.8. Comparison to Open and Closed States
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As part of the preliminary analysis, the RyR1 with Mg2+ and AMP-PCP was compared to the
closed and open structures determined by Samsó et al. (2009); the figures below show those
comparisons (Figure 35, 36, 37).26

Figure 35. Overall comparison of cytoplasmic (top) and side views from 3D density map of
RyR1 with Mg2+ and AMP-PCP to open and closed states of RyR1 from Samsó et al. (2009)26
Although difficult to analyze from the static images (more clear on a movie comparison), the
RyR1 appears to be in an intermediate conformation between the open and closeds states. In the
case of the transmembrane region at the site of the ion pore/gate, the RyR1 with Mg2+ and AMPPCP reflects more the configuration of the closed channel; that is, the pore region is more closed
than that of the open state.
The cytoplasmic region of the RyR1 reflects more the open state in two ways. Firstly, the Nterminal domains are more separated from one another, reflecting more the open conformation.
And secondly, the helical domains seem to twist more forward in the comparison to the closed
structure indicating that RyR1 with Mg2+ and AMP-PCP is in a state that is more similar to the
open conformation.
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Lastly, three features of the RyR1 appear unique and possibly the result of the addition of Mg2+
and AMP-PCP. Firstly, the P2 domains appear to move towards the SPRY3 domain. Secondly,
the P1 domain appears wider than in both the closed and open conformations. And lastly, the EF
hand motif on the underside of the cytoplasmic face of the RyR1 appears to enlarge, to move
towards the transmembrane region of the receptor, and to connect with the S2/S3 extension of
the transmembrane region.
The following figures, Figures 36 and 37, depict the ion gate as compared to the open and closed
conformations of RyR1 from Samsó et al. (2009) to assess if the channel at the ion gate is in an
open or closed configuration.26

Figure 36. Side view comparison of the ion gate (yellow cylinder) from the 3D density map of
RyR1 with Mg2+ and AMP-PCP to open and closed states of RyR1 from Samsó et al. (2009)26
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Figure 37. Cytoplasmic view comparison of the ion gate from the 3D density map of RyR1 with
Mg2+ and AMP-PCP to open and closed states of RyR1 from Samsó et al (2009)26
As indicated by the yellow cylinders of Figure 36, the central region of the transmembrane
region of the RyR1 corresponds to the ion gate, and it varies between the three density maps.
Part of the differences may be accounted for differences in resolutions and data sets, but the
channel shows other, clear differences. Relative to the first density map of the closed
conformation, the ion gate width of RyR1 with Mg2+ and AMP-PCP appears similar. However,
relative to the third density map of the open conformation, the ion gate width of RyR1 with
Mg2+/AMP-PCP is much more narrow.
This can be further visualized in Figure 37 using a section from the cytoplasmic (top) view of the
RyR1 at the level of the ion gate. The first panel of Figure 37 depicts the closed conformation,
the second depicts the density map of RyR1 with Mg2+ and AMP-PCP, and the third depicts the
open conformation. The central blue densities corresponding to RyR1 with Mg2+ and AMP-PCP
match well with the central green densities of the closed conformation, indicating that the two
are in a similar conformation. The central blue densities of RyR1 with Mg2+ and AMP-PCP do
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not match well with the central densities of the open conformation. As seen in the third panel, the
pore size of the open conformation is significantly larger than the density map of RyR1 with
Mg2+ and AMP-PCP indicating that the RyR1 is not in an open conformation. The minimum
diameter of each of the pores was measured in Chimera (software), and the diameter of the ion
gate in both the RyR1 with Mg2+ and AMP-PCP and the closed conformation was measured at
approximately 8 Å. The minimum diameter of the open was determined at 12 Å, which is 4 Å
larger than that of the RyR1 with Mg2+ and AMP-PCP. Despite this likely being sufficient to
state that the conformation is closed, a second comparison with the RyR1 at near-atomic
resolution was assessed to further validate these findings.21

3.5.9. Depiction of Ion Gate Compared to a Near-Atomic Map
As continued from the previous analysis, the ion gate structure was assessed once again to verify
if the RyR1 is in the open configuration or closed configuration; the following slice of the 3D
reconstruction depicts the ion gate as it is compared to the closed map of 3J8H (Figure 38).

72

Figure 38. Depiction of the ion gate in the 3D density map of RyR1 with Mg2+ and AMP-PCP
As indicated by the white arrow, the ion gate is at the very center of the slice of RyR1. The
lavender region corresponds to the density resolved by 3D refinement in Frealign, and the red
region corresponds the closed map of 3J8H. At the site of the ion gate, the structure with Mg2+
and AMP-PCP has a comparable pore size similar to or possibly smaller than that of the closed
state. Thus, it can be determined that this reconstruction is in a tightly closed state and that Mg2+
in the presence of AMP-PCP has an inhibiting effect.
As indicated by the white arrows, lavender densities of all 6 of the transmembrane helices are
present within the transmembrane region, and there is a significant degree of overlap between the
near-atomic closed configuration (3J8H) and the reconstruction with Mg2+ and AMP-PCP. This
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degree of overlap serves as partial validation that the overall structure of the transmembrane
region has been correctly resolved with Frealign.
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4. Discussion

4.1. Protein Purification
The protein purification protocol was adapted from previous protocols used in our laboratory; the
initial protocol did not require the addition of PC during the solubilization or sucrose gradient
separation, but the lack of PC resulted in denaturation of the RyR1. Following incorporation of
the PC to the protocol, no issues followed with regards to denaturation. Successful separation
during the sucrose gradients depended immensely on meticulous attention to detail to keep the
sucrose layers from mixing. The optimal protocol was to create the sucrose gradients as close to
the ultracentrifuge as possible in an effort to minimize the amount of movement following
creation the sucrose gradients. Also, addition of the protein sample to the sucrose gradients must
be done just as slowly as the sucrose layers as another effort to prevent mixing of different
layers.
Following sucrose gradient centrifugation, it was speculated that FKBP12 would not be bound to
the RyR1 due to the separation based on molecular weight. This was confirmed in both the 3D
reconstructions and in the 2D class averaging. FKBP12 was not added due to unpublished work
from our laboratory showing aggregation of RyR1 in the presence of FKBP12, Mg2+, and AMPPCP and showing no aggregation of RyR1 in the presence of Mg2+ and AMP-PCP.
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4.2. Nanodisc Ratio Determination and Successful Incorporation
The preliminary determination of a theoretical ratio of RyR1:MSP:POPC served as a starting
point for empirical testing. The ratio of 1:2:50 was chosen as it was close to the theoretical ratio
of 1:2:46 with a slight excess of POPC to account for any error. A ratio of 1:2:36 was tested as it
had proven successful in preliminary attempts by our laboratory, and the ratio of 1:4:72 was
chosen as a comparative point corresponding to double the MSP and POPC in the 1:2:36 ratio.
The ratio of 1:2:70 was chosen arbitrarily as empirical point significantly higher than the
theoretical.
Successful incorporation of the RyR1 into the nanodisc was based on the assumption that the
presence of no detergent leads to degradation and aggregation, and since the detergent was
dialyzed out following nanodisc formation, the RyR1 retaining its structural integrity is a
consequence of successful incorporation. The sample was negatively stained for a number of
reasons that include assessment of overall quality of RyR1, quality of RyR1 following insertion
into nanodisc, purity of RyR1, and readiness for cryo-EM grid preparation.
The receptor was assessed prior to and after incorporation into nanodiscs using a ratio of
RyR1:MSP:POPC of 1:2:36, and it was deemed successful due to the confirmed structural
integrity of the receptor with negative staining method. Of note, the nanodisc was later visualized
as a result of 3D reconstruction. This ratio of 1:2:36 was compared on two different occasions to
three different ratios. First, the ratios of 1:2:50 and 1:2:70 were assessed; both proved successful,
but the ratio of 1:2:70 lead to formation of large pockets of lipids that were thought to potentially
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alter the light scattering properties of the sample. The ratio of 1:2:36 was then compared to the
ratio of 1:4:72, and it was determined that doubling the concentrations of MSP and POPC
relative to RyR1 lead to a large increase in the number of free nanodiscs. The ratio of 1:2:70 was
also compared to the ratio of 1:4:72, and it was determined that use of more MSP with similar
amounts of POPC lead to minimization of the amount of free POPC accumulating as it became
incorporated into nanodiscs.
The preliminary decision was to use the ratios 1:2:36 as it incorporated a large portion of the
RyR1 and minimized the amount of free nanodiscs. Ultimately, the ratio of 1:2:50 was chosen as
it still minimized the amount of free nanodiscs but theoretically incorporated more RyR1. The
ratio of 1:4:72 was not chosen due to the superfluous number of free nanodiscs that would
require an extra step of purification to eliminate the excess.
The study is limited due to not testing the effect of dialyzing out the detergent without nanodiscs
present. At the testing stage, limited supplies of rabbit muscle and purified RyR1 prevented
testing a condition that would theoretically result in complete denaturation and aggregation of
the already limited RyR1 stock.
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4.3. Optimization of Cryo-EM Grid Preparation
A variety of parameters were altered to create a grid with thin enough ice to provide high
resolution but thick enough to allow for different views of the receptor. To achieve the result, the
parameters were altered systematically to assess the changes. The first parameter tested was presaturation; a cryogenic grid was visualized at room temperature before and after pre-saturation
with 3 µL of sample applied for 60 seconds. It was determined that the pre-saturation step
increased the occupancy of non-specific binding sites on the carbon support of the cryogenic
grid, which would ultimately lead to increased concentration of RyR1 after plunge-freezing. Of
note, the blotting following pre-saturation was performed by hand rather than using a Vitrobot.
This, consequently, lead to a large variability in the thickness of the ice while holding all the
other parameters constant. Nonetheless, the pre-saturation proved invaluable, so all freezing
proceeded using pre-saturation.
The second parameter altered was the current associated with the glow discharge. The current
was changed from 15 mA for 20 seconds to 25 mA for 20 seconds, but the difference in current
did not show significant difference. As a result, the value of 15 mA was chosen as it provided
sufficient concentration of protein and hydrophilicity of the grid.
Next, [NaCl] was altered following a preliminary test using 88 mM NaCl. The initial sample
preparation did not account for the additions of Mg2+, AMP-PCP, and EGTA needed to achieve
the final conditions, so the [NaCl] was lower than anticipated. It was noted that the RyR1
aggregated following these additions despite significantly less aggregation on preliminary
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sample checking during negative stain. Increasing the [NaCl] has been shown to decrease the
interaction between multiple RyR1 due to it limiting of potential ionic interactions.88
Consequently, it was found that increasing the [NaCl] to 500 mM lead to significantly less
aggregation, and this was the value used in the subsequent freezing.
Lastly, the different parameters of blot force, blot time, and chamber temperature were
manipulated. The results of these parameters proved less consistent than the previous parameters
tested, but some general trends were observed. Decreasing the blot force resulted in thicker ice,
so the blot force was decreased from 25 to 0. Decreasing the blot time resulted in thicker ice, so
the blot time was decreased from 2 seconds to 0.5 seconds. Lastly, decreasing the temperature of
the sample loading chamber resulted in less humidity contamination during freezing, so the
temperature was decreased from room temperature, 25ºC to 4ºC.
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4.4. Software Comparison Between Spider, Frealign, and Relion
Spider and Relion both have 2D class averaging; however, they differ immensely in the method
and the ultimate result. Spider uses a reference-based classification system that compares each
particle to projections of a 3D structure and determines a cross-correlation value that is used as
criteria for classification. This method provides for very nice figures and classes but falls short in
separating the particles from the non-particles because the non-particles are still placed in
classes. The cross-correlation value can be used to limit the number of non-particles
incorporated, but finding the threshold where only non-particles are omitted is a cumbersome
task.
Relion, on the other hand, uses a reference-free classification system that generates its own
averages based on comparing the selected particles to themselves. This proves valuable in
removing non-particles from the data set, but does not generate as many classes based on
projections. As a consequence, it becomes difficult to limit the number of particles of a certain
orientation as other orientations are grouped into classes that do not reflect the true orientation.
In the case of this particular data set, the 2D class averaging and classification done through
Spider served more valuable since the majority of the data fell into the first 3 categories of
cytoplasmic views, and with Spider, these classes were able to be capped at 15,000 particles to
prevent any artifact from forming. Following the 2D classification, the new data set consisting of
79,457 particles was submitted to both Relion and Frealign.
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Both structures resolved 3D reconstructions with a resolution of 9.06 Å; however, the structure
resulting from Frealign seemed to have more features/details despite the equivalent resolution. It
is likely that there is a common region between the two 3D reconstructions that is limiting the
achieved resolution, but Frealign was able to resolve more detail. With the incorporation of tilted
data, more visualizations of the side of the RyR1 will be attained and added to the data set, and
the resolution is expected to improve from 9.06 Å. Additionally, the ion gate and its pore were
visualized more clearly with Frealign, and the transmembrane helices extended past the nanodisc
in a manner more consistent with previously published reconstructions. It is likely that these
differences resulted from lack of side views rather than from issues within either software, but
for the sake of analysis, Frealign was more helpful in the current circumstance.
The resolution trends of the 3D structures deposited in the EMDataBank has been analyzed
based on the software package used to perform the 3D reconstruction. The following figure
depicts this analysis (Figure 39).83
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Figure 39. Graph of resolution trends based on software package of 3D structures deposited in
EMDataBank adapted from Lawson et al. (2016)83
Based on the figure above, Spider does not typically serve as a good 3D reconstruction software
as the average resolution of the 3D structures attained from the software is over 20 Å. Frealign
and Relion are comparable in regards to both highest resolution achieved and average resolution.
The highest resolution attained with Frealign is 1.8 Å, whereas the highest resolution attained
with Relion is 2.2 Å. The average resolution attained with Frealign is 10.5 Å, whereas the
average resolution attained with Relion is 8.1 Å. The differences in average resolution could
possibly be explained by the increasing number of people beginning to use Relion in preference
of Frealign. This result is in agreement with the results of the Relion and Frealign reconstruction
of RyR1 with Mg2+ and AMP-PCP as they both returned identical resolutions. Nonetheless, in
this particular incidence, Frealign proved slightly better for overall quality.
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4.5. Conformation Effects of Mg2+ and AMP-PCP on the RyR1
Based on results from the 3D reconstruction using both Relion and Frealign, the nanodisc was
resolved around the transmembrane region. This is, however, not the first successful
incorporation of the RyR1 into nanodiscs; the following figure shows the first published data of
RyR1 incorporated into a nanodisc (Figure 40).89

Figure 40. Cryo-EM density map depicting nanodisc adapted from Efremov et al. (2015)89
Although not the first incorporation, the optimization of the ratio of RyR1:MSP:POPC will
undoubtedly prove valuable to our laboratory in this and future endeavors. It is worthy to note
that the above diagram is currently the only published density map of RyR1 solubilized with
nanodiscs. Since the density map of RyR1 with Mg2+ and AMP-PCP shows an identical shape
and location of the nanodisc, the map depicting the nanodisc from Efremov is further validated.
The determination that RyR1 is closed in the presence of Mg2+ and AMP-PCP agrees with the
expected result. The concentrations of Mg2+ and AMP-PCP used were in an effort to mimic the
physiological state of the receptor, which is expected to be closed at rest given that the receptor
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does not allow Ca2+ through the channel unless activated. However, the cytoplasmic region
showed features of an open conformation.
In comparison to the structures of Samsó et al. (2009), the RyR1 with Mg2+ and AMP-PCP
appeared to be in an intermediate conformation, “primed” to the open state for Ca2+ release. The
cytoplasmic region of the RyR1 receptor reflected more the open conformation, whereas the
transmembrane region and the ion gate of the receptor reflected more the closed conformation.
Specifically, the N-terminal domain moved away from the pore region, and the helical domains
did not twist towards the center of the receptor, both reflecting more of an open conformation.
This opening effect may be the result of AMP-PCP having an activating/opening effect on the
receptor. The closing of the ion gate/pore region may, conversely, be a result of the Mg2+ having
an inhibitory effect, and the combined result leads to a primed channel with a closed ion gate and
open conformation at the cytoplasmic portion.
In addition, some features were observed unique to the structure of RyR1 with Mg2+ and AMPPCP. Those features (the stabilization and movement toward the SPRY3 domain of P2, the
widening of P1, and the movement downward and connection to the S2/S3 extension) may be a
result of the Mg2+, the AMP-PCP, or the combination of the two. Further study is needed to
assess if these differences are a consequence of Mg2+ and AMP-PCP or if they are a result of the
presence of the nanodisc or the lack of FKBP12. This may be assessed by preliminary
comparison to the previous structure with the nanodisc present and with closed structures
containing FKBP12. Nonetheless, the true assessment will come from other testing of the RyR1
with only Mg2+, only FKBP12, or only AMP-PCP present.
The biggest limitation of the structure is the resolution. Although an impressive 9.06 Å, the
resolution is still not high enough to determine the sites of Mg2+ binding, which remains an
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important aim of the study. With the upcoming incorporation of tilted data, the overall resolution
will increase to a point where the molecules of Mg2+ will hopefully be able to be visualized.
Criticism may come with regards to not incorporating the FKBP12 or to using a higher [NaCl]
than that of the physiological level. In regards to the FKBP12, unpublished aggregation lead to
its lack of incorporation. In regards to the [NaCl], the level of [NaCl] higher than physiological
levels was used as a means of preventing aggregation. Since Na+ has a minor activating effect
and since the RyR1 resolved from 3D reconstruction is in a very inactive (closed) state, it can be
inferred that Na+ did not significantly impact the conformation of the receptor
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4.6. The Role of RyR1, Mg2+, and AMP-PCP in Malignant Hyperthermia
With the Böttcher et al. (1997), Hewat et al. (2007) and Bammes et al. (2017) results regarding
the role of Mg2+ in malignant hyperthermia (MH) and in dantrolene treatment of MH, the
importance of the result of this study has undeniably increased.55,56,57 In the current state of the
3D reconstruction, determination that the receptor is in an inactive (closed) conformation
validates that Mg2+ plays a vital role in regulating the RyR1 in physiological conditions. As a
result, dysregulation of Mg2+ can be thought to lead to an open/leaky channel that is consistent
with the phenotype of MH, and this further validates the current model that MH is Mg2+
dependent.
Following further 3D analysis and successful depiction of the Mg2+ binding site, a number of
possibilities for further research will arise. Regulation studies regarding Mg2+ binding may be
assessed, new binding sites may be identified, and areas for new drug therapy may be explored.
Subsequent analysis regarding Mg2+ may be performed with the aim of testing known mutations
that lead to MH or CCD in an effort to assess if altering Mg2+ binding can lead to full closure of
the receptor from a leaky conformation. Additionally, one may incorporate dantrolene into these
experiments to further assess its conformational effects.
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